Methotrexate-induced epidermal necrosis in a child with osteosarcoma

J Dtsch Dermatol Ges. 2020 Sep;18(9):1028-1030. doi: 10.1111/ddg.14176. Epub 2020 Aug 20.

Authors

Alejandra Tomás-Velázquez¹, Nuria Rodríguez-Garijo¹, Ester Moreno-Artero¹, Elena Querol-Cisneros¹, Miriam Gutiérrez², Miguel Ángel Idoate³, Leyre Aguado¹

Affiliations

¹ Dermatology department, University Clinic of Navarra, Pamplona, Spain.
² Pediatric department, University Clinic of Navarra, Pamplona, Spain.
³ Pathology department, University Clinic of Navarra, Pamplona, Spain.

PMID: 32815265
DOI: 10.1111/ddg.14176

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antineoplastic Agents / adverse effects
Bone Neoplasms* / drug therapy
Doxorubicin / therapeutic use
Humans
Male
Methotrexate* / adverse effects
Methotrexate* / therapeutic use
Necrosis* / chemically induced
Osteosarcoma* / drug therapy

Substances

Antineoplastic Agents
Doxorubicin
Methotrexate